Published in Health Business Week, March 11th, 2005
Net income for the quarter was $955,000, or $0.04 per share on 23.0 million diluted shares outstanding, compared with a net loss of $817,000 or $0.04 per share on 19.5 million basic and diluted shares outstanding in the fourth quarter of 2003.
Net income for the year ended December 31, 2004, was $303,000, or $0.01 per share...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.